| Long name: |
Recombinant Vaccinia virus Interferon antagonist C7L (C7L) |
| Alternative names: |
Host range protein 2, Interferon antagonist C7, Interferon antagonist C7 |
| Gene name: |
C7L |
| Other gene names: |
C7L |
| General description: |
All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, coli, Interferon antagonist C7L (C7L) is a recombinant protein expressed in E |
| Product category: |
Recombinant Proteins |
| Expression system: |
coli, E |
| Available also expressed in:: |
Baculovirus , Mammalian Cell, Yeast , E Coli |
| Purity: |
Greater than 90% (determined by SDS-PAGE) |
| Form: |
Lyophilized protein |
| Storage: |
Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius |
| Applications: |
IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA |
| Description: |
MBS Recombinant Proteins produces more antagonist and receptor related products as 1, The antagonist receptor ligand binding will be in contrast with agonist activity |
| Gene target: |
Vaccinia virus Interferon antagonist C7L (C7L) |
| Short name: |
Vaccinia virus Interferon antagonist C7L (C7L) |
| Alternative name: |
Vaccinia virus Interferon antagonist C7L (C7L) |